Search Results

There are 13570 results for: content related to: New β-lactam–β-lactamase inhibitor combinations in clinical development

  1. You have free access to this content
    Posters

    Clinical Microbiology and Infection

    Volume 13, Issue s1, April 2007, Pages: S109–S608,

    Version of Record online : 26 MAR 2007, DOI: 10.1111/j.1469-0691.2007.01733.x

  2. You have free access to this content
    Poster Sessions

    Clinical Microbiology and Infection

    Volume 18, Issue s3, April 2012, Pages: 114–715,

    Version of Record online : 1 APR 2012, DOI: 10.1111/j.1469-0691.2012.03802.x

  3. You have free access to this content
    Posters

    Clinical Microbiology and Infection

    Volume 15, Issue s4, May 2009, Pages: S107–S612,

    Version of Record online : 22 MAY 2009, DOI: 10.1111/j.1469-0691.2009.02858.x

  4. You have free access to this content
    Posters

    Clinical Microbiology and Infection

    Volume 14, Issue s7, May 2008, Pages: S121–S666,

    Version of Record online : 7 APR 2008, DOI: 10.1111/j.1469-0691.2008.02007.x

  5. You have free access to this content
    Posters

    Clinical Microbiology and Infection

    Volume 16, Issue s2, April 2010, Pages: S133–S634,

    Version of Record online : 19 APR 2010, DOI: 10.1111/j.1469-0691.2010.03239.x

  6. Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 7, July 2015, Pages: 701–715, Jonathan C. Cho, Mallory A. Fiorenza and Sandy J. Estrada

    Version of Record online : 1 JUL 2015, DOI: 10.1002/phar.1609

  7. You have free access to this content
    In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae

    Clinical Microbiology and Infection

    Volume 20, Issue 11, November 2014, Pages: O831–O839, Y. Harada, Y. Morinaga, N. Kaku, S. Nakamura, N. Uno, H. Hasegawa, K. Izumikawa, S. Kohno and K. Yanagihara

    Version of Record online : 13 JUN 2014, DOI: 10.1111/1469-0691.12677

  8. You have free access to this content
    Foot & mouth disease

    Clinical Microbiology and Infection

    Volume 8, Issue s1, April 2002, Pages: 1–394,

    Version of Record online : 22 SEP 2006, DOI: 10.1111/j.1469-0691.2002.tb00013.x

  9. You have free access to this content
    Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients

    The Journal of Clinical Pharmacology

    Volume 55, Issue 8, August 2015, Pages: 899–908, Eun Kyoung Chung, S. Christian Cheatham, Megan R. Fleming, Daniel P. Healy, Katherine M. Shea and Michael B. Kays

    Version of Record online : 13 MAY 2015, DOI: 10.1002/jcph.505

  10. You have free access to this content
    13th European Congress of Clinical Microbiology and Infectious Diseases

    Clinical Microbiology and Infection

    Volume 9, Issue s1, May 2003, Pages: 1–422,

    Version of Record online : 8 MAY 2003, DOI: 10.1046/j.1469-0691.9.s1.83.x

  11. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 10, October 2015, Pages: 949–962, Keith S. Kaye and Jason M. Pogue

    Version of Record online : 24 OCT 2015, DOI: 10.1002/phar.1636

  12. You have free access to this content
    P1198 - P1459

    Clinical Microbiology and Infection

    Volume 12, Issue s4, April 2006, Page: no,

    Version of Record online : 24 MAR 2006, DOI: 10.1111/j.1470-9465.2006.12_4_1430.x

  13. You have free access to this content
    Abstracts cont.

    Clinical Microbiology and Infection

    Volume 11, Issue s2, April 2005, Pages: 99–237,

    Version of Record online : 23 MAR 2005, DOI: 10.1111/j.1469-0691.2005.clm_1134_01.x

  14. β-Lactam antimicrobials: what have you done for me lately?

    Annals of the New York Academy of Sciences

    Volume 1277, Issue 1, January 2013, Pages: 76–83, George H. Talbot

    Version of Record online : 29 NOV 2012, DOI: 10.1111/j.1749-6632.2012.06809.x

  15. You have full text access to this OnlineOpen article
    Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections

    The Journal of Clinical Pharmacology

    Volume 55, Issue 2, February 2015, Pages: 230–239, Gurudatt Chandorkar, Alan Xiao, Mohamad-Samer Mouksassi, Ellie Hershberger and Gopal Krishna

    Version of Record online : 14 NOV 2014, DOI: 10.1002/jcph.395

  16. You have free access to this content
    Cochrane Review: Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 6, Issue 6, November 2011, Pages: 2026–2185, Mical Paul, Dafna Yahav, Assaf Bivas, Abigail Fraser and Leonard Leibovici

    Version of Record online : 15 NOV 2011, DOI: 10.1002/ebch.879

  17. Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae

    APMIS

    Volume 119, Issue 12, December 2011, Pages: 853–863, EMILIA TITELMAN, AINA IVERSEN, GUNNAR KAHLMETER and CHRISTIAN G. GISKE

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1600-0463.2011.02766.x

  18. You have free access to this content
    Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin–clavulanate and piperacillin–tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.

    Clinical Microbiology and Infection

    Volume 16, Issue 2, February 2010, Pages: 132–136, L. López-Cerero, E. Picón, C. Morillo, J. R. Hernández, F. Docobo, J. Pachón, J. Rodríguez-Baño and A. Pascual

    Version of Record online : 15 JUL 2009, DOI: 10.1111/j.1469-0691.2009.02893.x

  19. Piperacillin-Tazobactam: A New β-Lactam-β-Lactamase Inhibitor Combination

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 2, March-April 1996, Pages: 149–162, Karen P. Daniel and Lynne C. Krop

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb02933.x

  20. You have full text access to this OnlineOpen article
    Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia

    The Journal of Clinical Pharmacology

    Volume 56, Issue 1, January 2016, Pages: 56–66, Alan J. Xiao, Benjamin W. Miller, Jennifer A. Huntington and David P. Nicolau

    Version of Record online : 25 AUG 2015, DOI: 10.1002/jcph.566